NCT07901088
A Bioequivalence and Safety Study of AJU-B718 and B718R in Healthy Adult Volunteers Under Fasting Conditions
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
AUCt of AJU-B718
Timeframe: Pre-dose(0 hours) ~ 24 hours
Cmax of AJU-B718
Timeframe: Pre-dose(0 hours) ~ 24 hours
Secondary (4)
AUCinf of AJU-B718
Tmax of AJU-B718
t1/2 of AJU-B718
AUCt/AUCinf of AJU-B718
Arms and interventions
Sequence AExperimental
Period 1: Reference Drug, Single dose / Period 2: Test Drug, Single dose / Period 3: Reference Drug, Single dose / Period 4: Test Drug, Single dose
Sequence BExperimental
Period 1: Test Drug, Single dose / Period 2: Reference Drug, Single dose / Period 3: Test Drug, Single dose / Period 4: Reference Drug, Single dose
Drugs: Test Drug, Reference Drug
Sites
1 site in 1 country
- H+ Yangji HospitalSeoul, Seoul, South Korea